Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Olav Oektedalen"'
Publikováno v:
HIV/AIDS - Research and Palliative Care. 8:165-174
Dyslipidemia, hypertension, inflammation, and coronary heart disease (CHD) are adverse events in human immunodeficiency virus (HIV)-infected patients even if they are receiving antiretroviral therapy (ART). Yet, data on CHD risk induced by HIV or ART
Autor:
Danai Tavonga Zhou, Babill Stray-Pedersen, Kerina Duri, Exnevia Gomo, Olav Oektedalen, Vitaris Kodogo
Publikováno v:
The Open AIDS Journal
Background:Dyslipidemia does not occur in all HIV-infected or antiretroviral therapy-experienced patients suggesting role of host genetic factors but there is paucity of data on association between dyslipidemia and gene polymorphisms in Zimbabwe.Obje
Autor:
Exnevia Gomo, Olav Oektedalen, Vitaris Kodogo, Kudzai Fortunate Vongai Chokuona, Babill Stray-Pedersen, Danai Tavonga Zhou
Publikováno v:
HIV/AIDS (Auckland, N.Z.)
Danai Tavonga Zhou,1,2 Vitaris Kodogo,1 Kudzai Fortunate Vongai Chokuona,1 Exnevia Gomo,1 Olav Oektedalen,3 Babill Stray-Pedersen21Department of Medical Laboratory Sciences, College of Health Sciences, University of Zimbabwe, Avondale, Zimbabwe; 2Ins
Autor:
Marius Trøseid, Susanne Dam Nielsen, Dag Kvale, Olav Oektedalen, Ingrid Os, Morten Baekken, Piotr Nowak, Ingjerd W. Manner
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 65:e158-e161
Autor:
Maria Pedersen, Olav Oektedalen, Piotr Nowak, Dag Kvale, Susanne Dam Nielsen, Ingjerd W. Manner, Ingrid Os, Marius Trøseid, Morten Baekken
Publikováno v:
HIV Medicine. 14:354-361
Objectives The aim of the study was to test the hypothesis that microbial translocation, quantified by levels of lipopolysaccharide (LPS) and subsequent monocyte activation [soluble (sCD14)], is associated with hypertension in HIV-infected individual
Publikováno v:
The Journal of Clinical Hypertension. 15:101-106
Hypertension is associated with cardiovascular disease in the human immunodeficiency virus (HIV)–infected population. The authors aimed to test the hypothesis whether advanced immunosuppression with low nadir CD4 lymphocyte cell count is a predicto
Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study
Publikováno v:
Blood Pressure. 21:311-319
Hypertension is a significant contributor to cardiovascular disease in HIV-infected individuals. The purposes of this study were to assess the development of new-onset hypertension and the use of antihypertensive treatment and blood pressure (BP) con
Publikováno v:
Blood Pressure. 19:188-195
There is a scarcity of data on ambulatory blood pressure (ABP) in HIV-infected individuals. The aim of the study was to identify possible predictors of ABP in HIV-infected individuals.From a cohort of 542 HIV-infected patients, ABP monitoring was und
Publikováno v:
Journal of Hypertension. 26:2126-2133
Hypertension is a major risk factor for cardiovascular diseases and mortality. The introduction of combination antiretroviral therapy for HIV-infected patients has changed their prognosis substantially, but there is an additional cost from the increa
Publikováno v:
J Clin Hypertens (Greenwich)
Hypertension is associated with cardiovascular disease in the human immunodeficiency virus (HIV)–infected population. The authors aimed to test the hypothesis whether advanced immunosuppression with low nadir CD4 lymphocyte cell count is a predicto